Univest Financial (UVSP) news
Recent news
China SXT Pharmaceuticals - To sell 8 mln class A shares at $1.5 per share
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) has announced plans to sell 8 million Class A ordinary shares at a price of $1.50 per share, according to recent reports. This offering is part of the company’s ongoing efforts to raise capital and strengthen its financial position. The offering will…
AInvest Wire · 6d agoUnivest Financial Q2 EPS USD 0.82
Univest Financial reported second-quarter earnings per share (EPS) of USD 0.82 for the period ending June 30, 2026[1]. This result reflects the company’s performance amid a mixed economic environment, with continued volatility in interest rates and shifting consumer demand. The earnings represent a…
AInvest Wire · Jul 22, 2026United Nova Technology says it, units plan to transfer, license technology to integrated circuit firm for 1.2 bln yuan
United Nova Technology Co., Ltd. (SSE: 688469) has announced plans to transfer and license technology to Xinlian Yuezhou Integrated Circuit Manufacturing (Shaoxing) Co., Ltd. for a total consideration of 1.2 billion yuan. The transaction is part of the company’s broader strategy to enhance its…
AInvest Wire · Jun 11, 2026United Nova Technology says it, partner plan 20 bln yuan 12-inch auto-grade chip project in Shaoxing
United Nova Technology (UNT), a Chinese semiconductor company listed on the Shanghai Stock Exchange (688469), has announced plans to collaborate on a 20 billion yuan project for the production of 12-inch auto-grade chips in Shaoxing, Zhejiang. The initiative aligns with the company’s strategic…
AInvest Wire · Jun 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.